Company intelligence / Profile preview

Puhua Capital

Hangzhou, China

Ownership: Private
Development stage: Other

Overview

Puhua Capital is a venture capital firm based in Hangzhou, China, specializing in early- and mid-stage investments with a strong focus on healthcare, biotechnology, and medical innovation. It invests in innovative life science companies developing diagnostics, therapeutics, and medical devices, with portfolio highlights in allergy, autoimmune, and oncology fields. It is a recognized partner for companies progressing from preclinical through clinical phases, and provides capital and strategic support to emerging firms, especially those innovating in diagnostics, medical devices, immune therapies, and digital health.

Therapeutic areas: ImmunologyOncologyOther
Modalities: Small moleculePeptideAntibodyProteinDevice
Industry: Investors

Partnerships

IDG Capital (Co-investor)Xiaomi (Co-investor)SIG China (Co-investor)

Beyond the preview

Go deeper on Puhua Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Puhua Capital.

Explore the full profile